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Abstract
Apocrine adenocarcinomas are rare malignant skin adnexal tumours. Apocrine carcinoma of the
nipple is extremely rare and this case to the author's knowledge is only the third reported case
worldwide and the first with associated ductal carcinoma in situ elsewhere in the breast. A seventy
one year old caucasian female presented to the breast clinic with a growth on her nipple which
proved on histopathological analysis to be an apocrine carcinoma. Recommended treatment for
apocrine carcinoma includes surgery in the form of wide local excision.
Introduction
Cutaneous ductal apocrine adenocarcinomas are
extremely rare malignant adnexal tumours [1,2]. Most of
these neoplasms involve the axilla. They have been
described in other areas as well. The progression of these
tumours is quite varied. The standard of care for these
lesions consists of wide local excision, with or without
lymph node dissection.
Case presentation
A seventy one year old Caucasian female presented to the
breast clinic with a painless growth on her right nipple of
six weeks duration. She gave no history of itchiness, dis-
charge or bleeding from the growth. She was otherwise
asymptomatic regarding her breasts.
She had previously had no breast problems and had no
family history of breast or ovarian carcinoma. She was
nulliparous and a teetotaller.
The only medical history of note was severe osteoarthritis
of her joints including her shoulder joints.
Clinical findings were threefold.
She had a polypoid hemispherical growth on her right
nipple measuring 40 by 25 mm. This appeared extremely
vascular with a necrotic slough covered surface (Figures 1
&2).
She was also found to have a clinically suspicious firm
lump measuring 25 by 25 mm in the lower outer quad-
rant at 8 o'clock position of her right breast 5 cm from the
nipple.
There were no palpable masses in her left breast nor pal-
pable lymph nodes in her right axilla. In her left axilla was
an enlarged firm lymph node 20 by 20 mm clinically
equivocal.
She had bilateral mammography, ultrasound scan of the
lower outer quadrant of her right breast and both axilla.
Right breast mammography showed a 30 mm radiologi-
cally malignant lesion in the lower outer quadrant of her
right breast. The left breast showed no suspicious features.
Ultrasound scan of the right axilla was normal. Ultra-
sound scan of her left axilla showed an enlarged lymph
node with poor corticomedullary differentiation; radio-
logically indeterminate.
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Cases Journal 2008, 1:88 http://www.casesjournal.com/content/1/1/88She had a clinical trucut biopsy of the lump in her right
breast and an ultrasound guided trucut biopsy of the inde-
terminate lymph node in her left axilla. Trucut biopsy of
the lump in the right breast lower outer quadrant showed
ductal carcinoma in situ. Trucut biopsy of the radiologi-
cally indeterminate lymph node in her left axilla showed
reactive changes only.
She went on to have right mastectomy with axillary node
sampling in the form of sentinel node biopsy.
The lump in in the lower outer quadrant of the breast was
found to be predominantly ductal carcinoma in situ of
intermediate and high grade of cribriform and apocrine
type. Associated with the ductal carcinoma in situ were
two small areas of invasive adenocarcinoma. These were
grade 3 carcinomas with no lymphovascular invasion,
negative oestrogen receptors and Her 2 status negative.
The proximal ducts approaching the nipple were unre-
markable. The nipple was entirely replaced by the poly-
poid lesion. There was too much cytological atypia to
consider this as a nipple adenoma. Purely on the basis of
cytology and architecture, the appearances were sugges-
tive of ductal carcinoma in situ. There was no evidence of
an invasive lesion in this area. The typical features of
Paget's disease of the nipple (intra epithelial tumour cells)
were not seen. Further immunohistochemistry was per-
formed on the nipple lesion. The tumour cells were nega-
tive for oestrogen receptors. Only an occasional smooth
muscle cell was demonstrable within the lesion. The
appearances therefore argued against a primary lesion of
breast epithelium and suggested instead a skin adnexal
tumour i.e. apocrine carcinoma.
Two lymph nodes were sampled which were free of
tumour.
Discussion
Apocrine adenocarcinoma is a rare malignant neoplasm
arising in areas where there is an abundance of apocrine
sweat glands [3]. When it occurs in the breast it is also
known as sweat gland carcinoma of the breast. The com-
mon site of occurrence is the axilla [4]. They have also
been described in other areas which include the scalp,
forehead, eyelid, upper lip, sub mandibular skin, chest,
pubic skin, nipple, arm, wrist, and finger [3]. Their pro-
gression has been found to be variable ranging from
weeks to years. Different studies suggest a preponderance
in males. Approximately half of patients with apocrine
carcinoma have been reported to have regional lymph
node metastases at the time of presentation [5]. The high-
est incidence is between the ages of 40 and 60.
Diagnostic Criteria [6,7] include
At least 75% of microscopic fields must demonstrate the
following major criteria
Large cells with abundant eosinophilic cytoplasm
Nucleus to cytoplasm ratio of 1:2 or more
Nuclei round, large and vesicular
Sharply defined cell borders
Minor (non-mandatory) criteria include
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Prominent nucleoli in > 50% of fields
Apical cytoplasmic snouts into lumenal spaces
The standard treatment consists of surgery in the form of
wide local excision, with or without lymph node dissec-
tion.
Apocrine carcinoma responds poorly to chemotherapy.
Adjuvant radiotherapy may be used in cases with
advanced local or regional lesions.
Conclusion
There are several pitfalls to be avoided when a patient
presents to with a nipple lesion. It is very tempting to con-
sider it as a solely nipple lesion and ignore the breast and
axilla. Full breast and axillary examination and triple
assessment is necessary to avoid missing any concomitant
tumour as in this case.
Majority of nipple lesions are benign and one needs to be
aware of malignant lesions of the nipple as these to avoid
delay in diagnosis and management.
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